<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885543</url>
  </required_header>
  <id_info>
    <org_study_id>ALIMA02</org_study_id>
    <nct_id>NCT04885543</nct_id>
  </id_info>
  <brief_title>COVID-19 STAndard of Care in Sub-Saharan Africa</brief_title>
  <acronym>COVISTA</acronym>
  <official_title>Observational Study of the Clinico-biological Evolution and the Standard of Care Offered to Symptomatic Covid-19 Patients in Sub-Saharan Africa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alliance for International Medical Action</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alliance for International Medical Action</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was conducted in three African countries on four COVID-19 care centers (CCCs). The&#xD;
      CCCs were set up in collaboration with a medical NGO with long experience in recording and&#xD;
      monitoring data for cohorts and clinical trials in emergency contexts. The data were recorded&#xD;
      using the WHO COVID-19 rapid core case report form.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>During hospitalization, with an average of 11 days</time_frame>
    <description>In hospital mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical worsening</measure>
    <time_frame>Hospitalization, with an average of 11 days</time_frame>
    <description>Combination of an SpO2 &lt;94% at least once during follow-up (including at baseline), use of oxygen therapy at any time during follow-up, or death</description>
  </secondary_outcome>
  <enrollment type="Actual">2495</enrollment>
  <condition>Covid19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        People hospitalized with symptomatic of COVID-19 and a positive RT-PCR SARS-CoV-2 test&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  SARS-CoV-2 positive at RT-PCR&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Asymptomatic patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denis Malvy, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Bordeaux, INSERM 1219</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chu Tengandogo</name>
      <address>
        <city>Ouagadougou</city>
        <zip>BP104</zip>
        <country>Burkina Faso</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Princesse Sarah</name>
      <address>
        <city>Ouagadougou</city>
        <zip>BP51145</zip>
        <country>Burkina Faso</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Donka</name>
      <address>
        <city>Conakry</city>
        <zip>BP834</zip>
        <country>Guinea</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Burkina Faso</country>
    <country>Guinea</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 6, 2021</study_first_submitted>
  <study_first_submitted_qc>May 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

